Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions
出版年份 2021 全文链接
标题
Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions
作者
关键词
-
出版物
Journal of Hepatocellular Carcinoma
Volume Volume 8, Issue -, Pages 741-757
出版商
Informa UK Limited
发表日期
2021-07-02
DOI
10.2147/jhc.s285726
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- γ-Secretase inhibitors for breast cancer and hepatocellular carcinoma: From mechanism to treatment
- (2021) Hui Jia et al. LIFE SCIENCES
- MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma
- (2020) Laura Gramantieri et al. CANCER RESEARCH
- RNA m 6 A methylation regulates sorafenib resistance in liver cancer through FOXO 3‐mediated autophagy
- (2020) Ziyou Lin et al. EMBO JOURNAL
- Role of the mTOR pathway in liver cancer: from molecular genetics to targeted therapies
- (2020) Xinjun Lu et al. HEPATOLOGY
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNA-375 represses tumor angiogenesis and reverses resistance to sorafenib in hepatocarcinoma
- (2020) Dong Li et al. CANCER GENE THERAPY
- Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic Heterogeneity
- (2020) Loraine Kay D. Cabral et al. Cancers
- Valproic acid reverses Sorafenib resistance through inhibiting activated Notch/Akt signaling pathway in HCC
- (2020) Xu Yang et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma
- (2020) Zhongqiang Zhang et al. Cell Death & Disease
- Mechanisms of Notch signaling: a simple logic deployed in time and space
- (2019) Domingos Henrique et al. DEVELOPMENT
- PFKFB3/HIF-1α feedback loop modulates sorafenib resistance in hepatocellular carcinoma cells
- (2019) Qian Long et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Nek2 augments sorafenib resistance by regulating the ubiquitination and localization of β-catenin in hepatocellular carcinoma
- (2019) Ling Deng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- PMPCB Silencing Sensitizes HCC Tumor Cells to Sorafenib Therapy
- (2019) Jian-feng Zheng et al. MOLECULAR THERAPY
- miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy
- (2019) Wen-Ping Xu et al. GUT
- The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma
- (2019) Ling Wei et al. Molecular Cancer
- Verteporfin-induced lysosomal compartment dysregulation potentiates the effect of sorafenib in hepatocellular carcinoma
- (2019) Jacopo Gavini et al. Cell Death & Disease
- Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC
- (2019) Lai Wei et al. Nature Communications
- MicroRNAs in Animal Models of HCC
- (2019) Francesca Fornari et al. Cancers
- LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function
- (2019) Fengyuan Tang et al. Nature Communications
- COX-2/PGE2 Axis Regulates HIF2α Activity to Promote Hepatocellular Carcinoma Hypoxic Response and Reduce the Sensitivity of Sorafenib Treatment
- (2018) Xiao-Feng Dong et al. CLINICAL CANCER RESEARCH
- Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib
- (2018) Man Tong et al. JOURNAL OF HEPATOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications
- (2018) Chun-Ming Wong et al. Nature Reviews Gastroenterology & Hepatology
- The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma
- (2018) Daniela Pollutri et al. Cell Death & Disease
- Inhibition of Cyclin-dependent Kinase 5 - a Novel Strategy to Improve Sorafenib Response in HCC Therapy
- (2018) Maximilian A. Ardelt et al. HEPATOLOGY
- Synergistic antitumor effect of a γ-secretase inhibitor PF-03084014 and sorafenib in hepatocellular carcinoma
- (2018) Xuran Yang et al. Oncotarget
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Notch Inhibitor PF-03084014 Inhibits Hepatocellular Carcinoma Growth and Metastasis via Suppression of Cancer Stemness due to Reduced Activation of Notch1–Stat3
- (2017) Chuan Xing Wu et al. MOLECULAR CANCER THERAPEUTICS
- The putative tumor suppressor microRNA-30a-5p modulates clear cell renal cell carcinoma aggressiveness through repression of ZEB2
- (2017) Zhenhua Chen et al. Cell Death & Disease
- Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)
- (2016) D. Koeberle et al. ANNALS OF ONCOLOGY
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Sorafenib metabolism, transport, and enterohepatic recycling: physiologically based modeling and simulation in mice
- (2016) Andrea N. Edginton et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways
- (2016) Yanmin Xu et al. CANCER LETTERS
- miR-181a induces sorafenib resistance of hepatocellular carcinoma cells through downregulation of RASSF1 expression
- (2016) Junya Azumi et al. CANCER SCIENCE
- Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF
- (2016) Jiwen Cheng et al. Oncotarget
- An artificial lncRNA targeting multiple miRNAs overcomes sorafenib resistance in hepatocellular carcinoma cells
- (2016) Shuyao Tang et al. Oncotarget
- Hepatocellular carcinoma
- (2016) Josep M. Llovet et al. Nature Reviews Disease Primers
- Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma
- (2015) Victoria Tovar et al. GUT
- The Histone Deacetylase Inhibitor Vaproic Acid Induces Cell Growth Arrest in Hepatocellular Carcinoma Cells via Suppressing Notch Signaling
- (2015) Guangchun Sun et al. Journal of Cancer
- Role of microRNA-30c Targeting ADAM19 in Colorectal Cancer
- (2015) Qian Zhang et al. PLoS One
- Notch3 inhibition enhances sorafenib cytotoxic efficacy by promoting GSK3β phosphorylation and p21 down-regulation in hepatocellular carcinoma
- (2015) Catia Giovannini et al. Oncotarget
- Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells
- (2014) Dali Zhao et al. CELLULAR SIGNALLING
- Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib
- (2014) Andrew X. Zhu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Alternative Mammalian Target of Rapamycin (mTOR) Signal Activation in Sorafenib-resistant Hepatocellular Carcinoma Cells Revealed by Array-based Pathway Profiling
- (2014) Mari Masuda et al. MOLECULAR & CELLULAR PROTEOMICS
- Inhibition of Akt Reverses the Acquired Resistance to Sorafenib by Switching Protective Autophagy to Autophagic Cell Death in Hepatocellular Carcinoma
- (2014) B. Zhai et al. MOLECULAR CANCER THERAPEUTICS
- In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer
- (2014) Ramona Rudalska et al. NATURE MEDICINE
- Activation of phosphatidylinositol 3-kinase/Akt signaling mediates sorafenib-induced invasion and metastasis in hepatocellular carcinoma
- (2014) HAIYONG WANG et al. ONCOLOGY REPORTS
- Establishment and Characterization of 7 Novel Hepatocellular Carcinoma Cell Lines from Patient-Derived Tumor Xenografts
- (2014) Hong Xin et al. PLoS One
- Diverse Mechanisms of AKT Pathway Activation in Human Malignancy
- (2013) Mitchell Cheung et al. CURRENT CANCER DRUG TARGETS
- Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma
- (2013) Yingjian Liang et al. HEPATOLOGY
- MicroRNA-494 within an oncogenic microRNA megacluster regulates G1/S transition in liver tumorigenesis through suppression of mutated in colorectal cancer
- (2013) Lionel Lim et al. HEPATOLOGY
- Phase I study investigating everolimus combined with sorafenib in patients with advanced hepatocellular carcinoma
- (2013) Richard S. Finn et al. JOURNAL OF HEPATOLOGY
- Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cells
- (2013) W-T Tai et al. Cell Death & Disease
- Sorafenib Inhibits Hypoxia-Inducible Factor-1 Synthesis: Implications for Antiangiogenic Activity in Hepatocellular Carcinoma
- (2012) L.-p. Liu et al. CLINICAL CANCER RESEARCH
- Notch Signaling Is Activated in Human Hepatocellular Carcinoma and Induces Tumor Formation in Mice
- (2012) Augusto Villanueva et al. GASTROENTEROLOGY
- PI3K regulation of the SKP-2/p27 axis through mTORC2
- (2012) K Shanmugasundaram et al. ONCOGENE
- Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis
- (2011) Ying-Hong Shi et al. Autophagy
- PI3K-AKT-FoxO axis in cancer and aging
- (2011) Guri Tzivion et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and Activity
- (2011) Sarat Chandarlapaty et al. CANCER CELL
- Adenosine triphosphate-binding cassette transporter genes up-regulation in untreated hepatocellular carcinoma is mediated by cellular microRNAs
- (2011) Florie Borel et al. HEPATOLOGY
- MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer
- (2011) Regalla Kumarswamy et al. INTERNATIONAL JOURNAL OF CANCER
- DLK1-DIO3 Genomic Imprinted MicroRNA Cluster at 14q32.2 Defines a Stemlike Subtype of Hepatocellular Carcinoma Associated with Poor Survival
- (2011) John M. Luk et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Activation of Phosphatidylinositol 3-Kinase/Akt Signaling Pathway Mediates Acquired Resistance to Sorafenib in Hepatocellular Carcinoma Cells
- (2011) K.-F. Chen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Everolimus Augments the Effects of Sorafenib in a Syngeneic Orthotopic Model of Hepatocellular Carcinoma
- (2011) A.-C. Piguet et al. MOLECULAR CANCER THERAPEUTICS
- Cells of origin in cancer
- (2011) Jane E. Visvader NATURE
- AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
- (2011) Joungmok Kim et al. NATURE CELL BIOLOGY
- Molecular Bases of Liver Cancer Refractoriness to Pharmacological Treatment
- (2010) J. Marin et al. CURRENT MEDICINAL CHEMISTRY
- The paradox of autophagy and its implication in cancer etiology and therapy
- (2009) Avital Eisenberg-Lerner et al. APOPTOSIS
- Sorafenib
- (2009) Gillian M. Keating et al. DRUGS
- Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells
- (2009) Junfang Ji et al. HEPATOLOGY
- The mTOR pathway is associated with the poor prognosis of human hepatocellular carcinoma
- (2009) Ledu Zhou et al. MEDICAL ONCOLOGY
- Effect of Rapamycin Alone and in Combination with Sorafenib in an Orthotopic Model of Human Hepatocellular Carcinoma
- (2008) Z. Wang et al. CLINICAL CANCER RESEARCH
- Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
- (2008) Augusto Villanueva et al. GASTROENTEROLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now